Drug Detail

Information about BMS 536924

Generic Name
IND
BMS 536924
Brand Name (US)
Manufacturer
Bristol-Myers Squibb
Drug Type
Tyrosine Kinase Inhibitor
Delivery
Oral
Approval Status
Phase 1
Indications
Overall Strategy
GIST cell based
Strategy
Block related tumor signal paths
Drug Category
IGF1R inhibitor

This is a IGF1R inhibitor in early development. IGF1R is overexpressed in 2/3 of wild-type GISTs and almost all pediatric GISTs.
Patients with wild-type GIST and pediatric GIST may be good candidates for a trial with inhibitors of IGF1R.


Links


Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed